| Bin Zhang | |
|---|---|
| Photo placeholder | |
| Affiliations | Icahn School of Medicine at Mount Sinai |
| Country | USA |
| H-index | 150 |
| ORCID | 0000-0001-6741-8382 |
| Research Focus | Alzheimer's Disease |
| Mechanisms | Genomics, Bioinformatics, Systems biology |
Bin Zhang is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Bin Zhang is a leading researcher in the field of neurodegenerative diseases, affiliated with Icahn School of Medicine at Mount Sinai. Their research focuses on Genomics, Bioinformatics, Systems biology, with particular emphasis on Alzheimer's Disease. With an h-index of 150, Zhang is among the most cited researchers in the neuroscience field.
Zhang's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's Disease. Their research group has made significant contributions to the fields of Genomics, Bioinformatics, Systems biology, publishing in high-impact journals including leading neuroscience journals.
Based at Icahn School of Medicine at Mount Sinai, Zhang collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.
[Alison M. Goate--TEMP--/researchers)--FIX--, [Eric E. Schadt--TEMP--/researchers)--FIX--
Dr. Bin Zhang has made significant contributions to understanding the genetic and genomic basis of Alzheimer's disease through sophisticated computational and systems biology approaches.
The Zhang laboratory applies cutting-edge genomic technologies and bioinformatics pipelines to identify genetic risk factors for Alzheimer's disease. This includes genome-wide association studies (GWAS), whole-exome sequencing, and transcriptomic analyses of brain tissue.
By integrating multiple data types - genomic, transcriptomic, proteomic, and epigenomic - the Zhang group constructs comprehensive models of Alzheimer's disease pathogenesis. These systems-level approaches reveal novel pathways and therapeutic targets.
Research in the Zhang lab includes identification of blood-based biomarkers for early detection and disease progression monitoring. This work has potential for developing minimally invasive diagnostic tools.
Current research focuses on:
Dr. Zhang has mentored numerous trainees who have gone on to careers in computational biology and neuroscience research.
The study of Bin Zhang has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-02-26.
Bin Zhang is a Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai. His research integrates computational biology, systems neuroscience, and artificial intelligence to understand complex brain disorders and develop novel therapeutic approaches.
Zhang's laboratory has developed innovative computational frameworks for analyzing complex biomedical data, leading to the identification of novel therapeutic targets and biomarkers for Alzheimer's disease. His work on the Module Map approach has been widely adopted for studying complex diseases.
Bin Zhang is a Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai. His research integrates computational biology, systems neuroscience, and artificial intelligence to understand complex brain disorders and develop novel therapeutic approaches.
Zhang's laboratory has developed innovative computational frameworks for analyzing complex biomedical data, leading to the identification of novel therapeutic targets and biomarkers for Alzheimer's disease. His work on the Module Map approach has been widely adopted for studying complex diseases. He has established large-scale collaborative networks integrating data from multiple international cohorts.
Current research focuses on applying graph neural networks to predict disease progression and treatment response, as well as developing explainable AI models for clinical decision support in dementia diagnosis.
Dr. Zhang has authored over 200 publications, including papers on:
His work integrates computational and experimental approaches.
Dr. Zhang's research has advanced precision medicine by:
Dr. Zhang has received awards for computational biology and systems neuroscience research.
Dr. Bin Zhang has made significant contributions to understanding the genetic and genomic basis of Alzheimer's disease through sophisticated computational and systems biology approaches.
The Zhang laboratory applies cutting-edge genomic technologies and bioinformatics pipelines to identify genetic risk factors for Alzheimer's disease. This includes genome-wide association studies (GWAS), whole-exome sequencing, and transcriptomic analyses of brain tissue.
By integrating multiple data types - genomic, transcriptomic, proteomic, and epigenomic - the Zhang group constructs comprehensive models of Alzheimer's disease pathogenesis. These systems-level approaches reveal novel pathways and therapeutic targets.
Research in the Zhang lab includes identification of blood-based biomarkers for early detection and disease progression monitoring. This work has potential for developing minimally invasive diagnostic tools.
Current research focuses on:
Dr. Zhang has mentored numerous trainees who have gone on to careers in computational biology and neuroscience research.